Design of an algorithm to support community pharmacy dyspepsia management |
| |
Authors: | Halldora A E Aradottir and Moira Kinnear |
| |
Institution: | (1) NHS Lothian Pharmacy Practice Unit, Department of Pharmacy, Western General Hospital, Crewe Road, Edinburgh, Scotland;(2) Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, Scotland;(3) Islenskar lyfjarannsoknir ehf – Encode, Krokhals 5d, 110 Reykjavik, Iceland |
| |
Abstract: | Objectives To design a care pathway and referral documentation system to support dyspepsia management in the community pharmacy according
to national guidelines. To explore attitudes of community pharmacists and general practitioners (GPs) towards the proposed
model of care. Setting Focus group of four community pharmacists from one locality and one-to-one interviews with five GPs in each of their surgeries
in different city localities. Method Literature review; design of a care pathway and referral system; qualitative analysis of focus group discussion and one-to-one
interviews. Main outcome measure Modified design of documentation system; attitudes and barriers towards an extended role for pharmacists in a community pharmacy
based model of individual care of patients with dyspepsia. Results The care pathway and documentation system was modified to make it simple to use and to assure appropriate referral and reporting
to GPs. All participants agreed that the SIGN guideline for Dyspepsia and local dyspepsia guidelines provide an opportunity
to extend the role of pharmacists to prescribe therapeutic doses of H2 receptor antagonists, test for Helicobacter pylori in the pharmacy and prescribe eradication therapy. Perceived advantages to patients included better convenience and reduced
waiting times for H. pylori testing. Current barriers to this model identified were: medico-legal issues, budgetary issues, limited access to patient
data, lack of privacy to talk to patients, inadequate time and remuneration, no patient registration, patients describing
vague symptoms and patient confidence in pharmacists. Conclusion The proposed model of care and documentation system for community pharmacy based dyspepsia management generated a favourable
response and design contributions from community pharmacists and GPs. Barriers were identified which have to be overcome prior
to implementation and evaluation of the model.
This study was conducted by the lead author when based in NHS Lothian, Scotland to undertake an MSc in Clinical Pharmacy at
University of Strathclyde, Glasgow. |
| |
Keywords: | Care pathway Community pharmacy Dyspepsia Extended role Guidelines Partnership working Pharmacists Scotland |
本文献已被 SpringerLink 等数据库收录! |
|